Daxor expands blood volume analysis technology across three networks

Daxor (DXR) announces a significant expansion into three regional healthcare facilities across the U.S. Recent sales wins include: A Midwest academic medical center has integrated Daxor’s BVA technology to enhance outpatient cardiovascular care; a Wisconsin primary health center has deployed Daxor’s BVA solution to improve outpatient syncope assessment and treatment; A cardiovascular care program in Southern New Jersey has adopted Daxor’s BVA technology across inpatient and outpatient setting.